• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴细胞减少诱导的淋巴细胞增殖驱动初始T细胞的激活和调节性群体的扩增。

Lymphopenia-induced lymphoproliferation drives activation of naive T cells and expansion of regulatory populations.

作者信息

Eldershaw S, Verma K, Croft W, Rai T, Kinsella F A M, Stephens C, Chen H, Nunnick J, Zuo J, Malladi R, Moss P

机构信息

Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.

Centre for Computational Biology, University of Birmingham, Birmingham, UK.

出版信息

iScience. 2021 Feb 7;24(3):102164. doi: 10.1016/j.isci.2021.102164. eCollection 2021 Mar 19.

DOI:10.1016/j.isci.2021.102164
PMID:33665580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7907823/
Abstract

Chemotherapy pre-conditioning is an essential component of chimeric antigen receptor transduced cell therapy. Acute lymphopenia-induced proliferation (LIP) is known to be driven primarily by homeostatic cytokines, but little is known on the underlying mechanisms in humans. We undertook phenotypic and transcriptional analysis of T cells undergoing LIP two weeks post-myeloablative autograft stem cell transplantation. Strong IL-7 signaling was reflected in downregulated IL-7R expression on all T cells, including naive cells, along with parallel increased IL-2Rα expression. Notably, activated residual naive cells expressed Fas indicating recent TCR engagement. Moreover, proportion of Ki67 + FoxP3+ Tregs was almost doubled. Transcriptional analysis revealed increased fatty acid metabolism and interferon signaling responses. In contrast, TGF-β signaling was strongly suppressed. Thus, human LIP response is characterized by cytokine and TCR-driven proliferation which drives global T cell activation but also preferentially triggers regulatory cell expansion which may limit tumor-specific immunity. These features indicate potential therapeutic opportunities to manipulate immunotherapy regimens incorporating LIP conditioning protocols.

摘要

化疗预处理是嵌合抗原受体转导细胞疗法的重要组成部分。急性淋巴细胞减少诱导增殖(LIP)主要由稳态细胞因子驱动,但人类潜在机制尚不清楚。我们对清髓性自体造血干细胞移植两周后经历LIP的T细胞进行了表型和转录分析。强烈的IL-7信号反映在所有T细胞(包括幼稚细胞)上IL-7R表达下调,同时IL-2Rα表达平行增加。值得注意的是,活化的残留幼稚细胞表达Fas,表明近期TCR参与。此外,Ki67 + FoxP3 + Tregs的比例几乎翻倍。转录分析显示脂肪酸代谢和干扰素信号反应增加。相比之下,TGF-β信号被强烈抑制。因此,人类LIP反应的特征是细胞因子和TCR驱动的增殖,这驱动了整体T细胞活化,但也优先触发调节性细胞扩增,这可能会限制肿瘤特异性免疫。这些特征表明了操纵包含LIP预处理方案的免疫治疗方案的潜在治疗机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf16/7907823/92b620d71ccf/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf16/7907823/b8603c937aed/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf16/7907823/97b53a2703cf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf16/7907823/d5603d2bb8ff/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf16/7907823/614e35bccf51/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf16/7907823/ef8ed162b4fb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf16/7907823/56c21dfa2885/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf16/7907823/1ec12a847142/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf16/7907823/92b620d71ccf/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf16/7907823/b8603c937aed/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf16/7907823/97b53a2703cf/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf16/7907823/d5603d2bb8ff/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf16/7907823/614e35bccf51/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf16/7907823/ef8ed162b4fb/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf16/7907823/56c21dfa2885/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf16/7907823/1ec12a847142/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf16/7907823/92b620d71ccf/gr7.jpg

相似文献

1
Lymphopenia-induced lymphoproliferation drives activation of naive T cells and expansion of regulatory populations.淋巴细胞减少诱导的淋巴细胞增殖驱动初始T细胞的激活和调节性群体的扩增。
iScience. 2021 Feb 7;24(3):102164. doi: 10.1016/j.isci.2021.102164. eCollection 2021 Mar 19.
2
The Abundance and Availability of Cytokine Receptor IL-2Rβ (CD122) Constrain the Lymphopenia-Induced Homeostatic Proliferation of Naive CD4 T Cells.细胞因子受体 IL-2Rβ(CD122)的丰富度和可获得性限制了 naïve CD4 T 细胞的淋巴细胞减少诱导的稳态增殖。
J Immunol. 2020 Jun 15;204(12):3227-3235. doi: 10.4049/jimmunol.1901276. Epub 2020 May 11.
3
Partial CD25 Antagonism Enables Dominance of Antigen-Inducible CD25 FOXP3 Regulatory T Cells As a Basis for a Regulatory T Cell-Based Adoptive Immunotherapy.部分CD25拮抗作用可使抗原诱导的CD25⁺FOXP3⁺调节性T细胞占优势,作为基于调节性T细胞的过继性免疫治疗的基础。
Front Immunol. 2017 Dec 14;8:1782. doi: 10.3389/fimmu.2017.01782. eCollection 2017.
4
Regulatory CD4+CD25+Foxp3+ T cells selectively inhibit the spontaneous form of lymphopenia-induced proliferation of naive T cells.调节性CD4+CD25+Foxp3+ T细胞选择性抑制淋巴细胞减少诱导的幼稚T细胞自发增殖形式。
J Immunol. 2008 Jun 1;180(11):7305-17. doi: 10.4049/jimmunol.180.11.7305.
5
The Role of TNFR2 and DR3 in the In Vivo Expansion of Tregs in T Cell Depleting Transplantation Regimens.在 T 细胞耗竭性移植方案中,TNFR2 和 DR3 在 Tregs 体内扩增中的作用。
Int J Mol Sci. 2020 May 9;21(9):3347. doi: 10.3390/ijms21093347.
6
IL-18 synergizes with IL-7 to drive slow proliferation of naive CD8 T cells by costimulating self-peptide-mediated TCR signals.白细胞介素-18与白细胞介素-7协同作用,通过共刺激自身肽介导的T细胞受体信号,促使初始CD8 T细胞缓慢增殖。
J Immunol. 2014 Oct 15;193(8):3992-4001. doi: 10.4049/jimmunol.1400396. Epub 2014 Sep 8.
7
Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4CD25Foxp3 and CD4CD25Foxp3 T cells.阻断 TGF-β 信号转导增强抗肿瘤反应的同时,也伴随着 CD4CD25Foxp3 和 CD4CD25Foxp3 T 细胞功能活性的失调。
J Transl Med. 2019 Jul 9;17(1):219. doi: 10.1186/s12967-019-1967-3.
8
Antigen-nonspecific activation of CD8+ T lymphocytes by cytokines: relevance to immunity, autoimmunity, and cancer.细胞因子对CD8 + T淋巴细胞的抗原非特异性激活:与免疫、自身免疫和癌症的相关性。
Arch Immunol Ther Exp (Warsz). 2008 Sep-Oct;56(5):311-23. doi: 10.1007/s00005-008-0033-2.
9
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
10
PD-1 Controls Tonic Signaling and Lymphopenia-Induced Proliferation of T Lymphocytes.程序性死亡受体1(PD-1)调控T淋巴细胞的张力信号传导及淋巴细胞减少诱导的增殖。
Front Immunol. 2017 Oct 12;8:1289. doi: 10.3389/fimmu.2017.01289. eCollection 2017.

引用本文的文献

1
Suppression of the T-dependent antibody response following oral exposure to selected polycyclic aromatic compounds in B6C3F1/N mice.B6C3F1/N小鼠经口暴露于选定的多环芳烃化合物后对T细胞依赖性抗体反应的抑制作用。
Front Toxicol. 2025 Mar 6;7:1558639. doi: 10.3389/ftox.2025.1558639. eCollection 2025.
2
Early inflammatory markers as prognostic indicators following allogeneic stem cell transplantation.异基因干细胞移植后早期炎症标志物作为预后指标。
Front Immunol. 2024 Jan 3;14:1332777. doi: 10.3389/fimmu.2023.1332777. eCollection 2023.
3
Immune Checkpoint Inhibitors Targeting the PD-1/PD-L1 Pathway in Advanced, Recurrent Endometrial Cancer: A Scoping Review with SWOT Analysis.

本文引用的文献

1
The transcription factor c-Myb regulates CD8 T cell stemness and antitumor immunity.转录因子 c-Myb 调控 CD8+T 细胞干性和抗肿瘤免疫。
Nat Immunol. 2019 Mar;20(3):337-349. doi: 10.1038/s41590-018-0311-z. Epub 2019 Feb 18.
2
Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial.白细胞介素-7 可恢复脓毒性休克中的淋巴细胞:IRIS-7 随机临床试验。
JCI Insight. 2018 Mar 8;3(5):98960. doi: 10.1172/jci.insight.98960.
3
Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma.
针对晚期复发性子宫内膜癌中PD-1/PD-L1通路的免疫检查点抑制剂:一项基于SWOT分析的范围综述
Cancers (Basel). 2023 Sep 19;15(18):4632. doi: 10.3390/cancers15184632.
4
Beyond lymphopenia, unraveling radiation-induced leucocyte subpopulation kinetics and mechanisms through modeling approaches.超越淋巴细胞减少症,通过建模方法揭示辐射诱导的白细胞亚群动力学和机制。
J Exp Clin Cancer Res. 2023 Feb 22;42(1):50. doi: 10.1186/s13046-023-02621-4.
5
Post-Treatment Neutrophil and Lymphocyte Counts Predict Progression-Free Survival Following First-Line Chemotherapy in Hodgkin's Lymphoma.治疗后中性粒细胞和淋巴细胞计数可预测霍奇金淋巴瘤一线化疗后的无进展生存期。
Hematol Rep. 2023 Feb 10;15(1):108-118. doi: 10.3390/hematolrep15010012.
6
Early expression of CD94 and loss of CD96 on CD8+ T cells after allogeneic stem cell tranplantation is predictive of subsequent relapse and survival.异基因干细胞移植后 CD8+T 细胞上 CD94 的早期表达和 CD96 的丢失可预测随后的复发和生存。
Haematologica. 2023 Feb 1;108(2):433-443. doi: 10.3324/haematol.2021.280497.
7
Anti-PD-L1/TGF-βR fusion protein (SHR-1701) overcomes disrupted lymphocyte recovery-induced resistance to PD-1/PD-L1 inhibitors in lung cancer.抗 PD-L1/TGF-βR 融合蛋白(SHR-1701)克服了肺癌中淋巴细胞恢复紊乱引起的对 PD-1/PD-L1 抑制剂的耐药性。
Cancer Commun (Lond). 2022 Jan;42(1):17-36. doi: 10.1002/cac2.12244. Epub 2022 Jan 3.
8
Barriers to Immunotherapy in Ovarian Cancer: Metabolic, Genomic, and Immune Perturbations in the Tumour Microenvironment.卵巢癌免疫治疗的障碍:肿瘤微环境中的代谢、基因组和免疫扰动
Cancers (Basel). 2021 Dec 11;13(24):6231. doi: 10.3390/cancers13246231.
经工程改造以克服肿瘤免疫逃逸的肿瘤特异性 T 细胞可诱导复发霍奇金淋巴瘤患者产生临床应答。
J Clin Oncol. 2018 Apr 10;36(11):1128-1139. doi: 10.1200/JCO.2017.74.3179. Epub 2018 Jan 9.
4
Interleukin-7 Availability Is Maintained by a Hematopoietic Cytokine Sink Comprising Innate Lymphoid Cells and T Cells.白细胞介素-7 的可利用性由先天淋巴细胞和 T 细胞组成的造血细胞因子汇维持。
Immunity. 2017 Jul 18;47(1):171-182.e4. doi: 10.1016/j.immuni.2017.07.005.
5
TGF-β inhibits IL-7-induced proliferation in memory but not naive human CD4 T cells.转化生长因子-β抑制记忆性而非初始人类CD4 T细胞中白细胞介素-7诱导的增殖。
J Leukoc Biol. 2017 Aug;102(2):499-506. doi: 10.1189/jlb.3A1216-520RR. Epub 2017 Jun 6.
6
CD45-mediated control of TCR tuning in naïve and memory CD8 T cells.CD45 介导的初始和记忆 CD8 T 细胞 TCR 激活的调控。
Nat Commun. 2016 Nov 14;7:13373. doi: 10.1038/ncomms13373.
7
Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen.肿瘤浸润淋巴细胞过继细胞疗法联合改良 IL2 方案治疗转移性黑色素瘤患者的持久完全应答。
Clin Cancer Res. 2016 Aug 1;22(15):3734-45. doi: 10.1158/1078-0432.CCR-15-1879. Epub 2016 Mar 22.
8
Exit Strategies: S1P Signaling and T Cell Migration.退出策略:鞘氨醇-1-磷酸信号传导与T细胞迁移
Trends Immunol. 2015 Dec;36(12):778-787. doi: 10.1016/j.it.2015.10.005.
9
Selective Treg reconstitution during lymphopenia normalizes DC costimulation and prevents graft-versus-host disease.淋巴细胞减少期间的选择性调节性T细胞重建可使树突状细胞共刺激正常化并预防移植物抗宿主病。
J Clin Invest. 2015 Sep;125(9):3627-41. doi: 10.1172/JCI76031. Epub 2015 Aug 24.
10
Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy.化疗耐药效应性T细胞和调节性T细胞在淋巴细胞清除化疗后抗肿瘤免疫中的关键作用
J Immunol. 2015 Jul 15;195(2):726-35. doi: 10.4049/jimmunol.1401468. Epub 2015 Jun 3.